Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8228106 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 8 Pages |
Abstract
This is the first Phase III, multicenter, adjuvant protocol for pancreatic adenocarcinoma to evaluate the impact of adherence to specified RT protocol guidelines on protocol outcomes. Failure to adhere to specified RT guidelines was associated with reduced survival and, for patients receiving gemcitabine, trend toward increased nonhematologic toxicity.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Ross A. M.D., Kathryn A. M.S., William F. M.D., Howard M.D., John P. M.D., Robert M.D., Andre A. M.D., Al B. M.D., John S. M.D., Tyvin A. M.D., Christopher G. M.D.,